KR20220113900A - Fungal infections treating device - Google Patents

Abstract

Provided is a fungal infection treatment device that comprises: a housing; a treatment space formed inside the housing and accommodating a treatment site; a treatment module for emitting light to the treatment space; a light amount measuring part for measuring the amount of light emitted to the treatment space; and a treatment module driving part for driving the treatment module to maintain the amount of light measured by the light amount measuring part within a preset range.

Description

Device for treating fungal infection {FUNGAL INFECTIONS TREATING DEVICE}

The present invention relates to a device for treating a fungal infection.

Athlete's foot is one of the skin diseases caused by ringworm belonging to a type of fungus. As a treatment method for such athlete's foot, there is a method of taking a drug or applying it to the skin. However, in the case of taking the drug, it cannot be used for patients with impaired liver function because there is a problem that can put a burden on the organs, its use for pregnant women is very limited, and there are many limitations in combination with other drugs due to the nature of the drug. There are many cases in which oral medication cannot be administered even with ringworm. When applied to the skin, the appearance is not good, and there is a cumbersome application of the drug frequently. Therefore, a recently used method is a method of killing athlete's foot by irradiating laser light. However, the conventional method of irradiating laser light has a disadvantage of having a complicated structure to directly irradiate the laser light to the location where athlete's foot bacteria exists.

The present invention provides a fungal infection treatment device for treating a fungus in a patient.

The present invention provides an apparatus for treating a fungal infection that can be used for a long time, and at least one of a current and a voltage applied to the treatment module may be adjusted so that the amount of light measured by the light amount measurement unit maintains a preset level.

A fungal infection treatment apparatus according to an embodiment of the present invention includes a housing, a treatment space formed inside the housing and capable of accommodating a treatment site, a treatment module irradiating light into the treatment space, and the treatment space. and a light quantity measuring unit for measuring the amount of light to be irradiated, and a treatment module driving unit for driving the treatment module so that the amount of light measured by the light quantity measuring unit maintains a preset range.

The apparatus may further include a compensation unit configured to transmit a compensation signal to the treatment module driver so that the amount of light measured by the light amount measurement unit is greater than a preset reference light amount.

Also, the compensation unit may transmit the compensation signal to the treatment module driver to increase at least one of a current and a voltage applied to the treatment module.

In addition, in the first mode of the fungal infection treatment device, the treatment module driving unit applies a current or voltage less than the maximum allowable current or the maximum allowable voltage of the treatment module to the treatment module, and the amount of light measured by the light quantity measurement unit is The second mode is activated below the reference light amount, and a current or voltage greater than the voltage or current of the first mode may be applied to the treatment module.

In addition, the current or voltage applied in the second mode may be the level of the maximum allowable current or the maximum allowable voltage.

The fungal infection treatment apparatus according to the present invention can effectively treat the fungus, and the efficiency does not decrease even if it is operated for a long time. Since the fungal infection treatment apparatus according to the present invention has a set amount or wavelength of light irradiated from the treatment module, it is possible to maintain high treatment efficiency even when used for a long time. Of course, the scope of the present invention is not limited by these effects.

1 is a view showing an apparatus for treating a fungal infection according to an embodiment of the present invention.
2 is a perspective view illustrating an apparatus for treating a fungal infection according to an embodiment of the present invention.
3 and 4 are views showing the operation of the fungal infection treatment apparatus of FIG.
FIG. 5 is a view showing a treatment module mounted in the interior of FIG. 2 .
6 and 7 are diagrams illustrating a state of use of the treatment module of FIG. 5 .
8 is a perspective view illustrating the treatment module of FIG. 5 ;
FIG. 9 is a view showing a cross-section of the treatment module of FIG. 8 .
10 is a block diagram illustrating a partial configuration of an apparatus for treating a fungal infection according to an embodiment of the present invention.
11 and 12 are views showing the arrangement of the light quantity measuring unit of FIG. 10 .
13 is a graph illustrating the control of the amount of light and the current or voltage according to the operation of the apparatus for treating a fungal infection according to an embodiment of the present invention.
14 is a flowchart illustrating a method for controlling the amount of light in the apparatus for treating a fungal infection according to another embodiment of the present invention.

Since the present invention can apply various transformations and can have various embodiments, specific embodiments are illustrated in the drawings and described in detail in the detailed description. Effects and features of the present invention, and a method for achieving them, will become apparent with reference to the embodiments described below in detail in conjunction with the drawings. However, the present invention is not limited to the embodiments disclosed below and may be implemented in various forms.

Hereinafter, embodiments of the present invention will be described in detail with reference to the accompanying drawings, and when described with reference to the drawings, the same or corresponding components are given the same reference numerals, and the overlapping description thereof will be omitted. .

In the following examples, the singular expression includes the plural expression unless the context clearly dictates otherwise.

In the following embodiments, terms such as include or have means that the features or components described in the specification are present, and the possibility that one or more other features or components may be added is not excluded in advance.

In cases where certain embodiments are otherwise practicable, a specific process sequence may be performed different from the described sequence. For example, two processes described in succession may be performed substantially simultaneously, or may be performed in an order opposite to the order described.

In the drawings, the size of the components may be exaggerated or reduced for convenience of description. For example, since the size and thickness of each component shown in the drawings are arbitrarily indicated for convenience of description, the following embodiment is not necessarily limited to the illustrated bar.

1 is a view showing an apparatus for treating a fungal infection according to an embodiment of the present invention.

Referring to FIG. 1 , the fungal infection treatment apparatus 100 may remove the fungus of the foot or toenail by inserting the user's foot. The fungal infection treatment apparatus 100 may diagnose or treat athlete's foot.

Although the drawing shows that both feet are inserted into the fungal infection treatment apparatus 100, the present invention is not limited thereto, and only one foot may be inserted for treatment.

2 is a perspective view illustrating an apparatus 100 for treating a fungal infection according to an embodiment of the present invention, and FIGS. 3 and 4 are views illustrating the operation of the apparatus 100 for treating a fungal infection of FIG. 2 .

2 to 4 , the fungal infection treatment apparatus 100 may include a housing 110 , a support 120 , a display unit 130 , and a cover 140 .

The housing 110 forms an external shape of the fungal infection treatment apparatus 100 , and the display unit 130 is disposed on one side. The housing 110 has an inlet 110A for inserting a foot or hand.

The support 120 may be supported by a foot or a hand. The support 120 is connected to the treatment space disposed inside the housing 110 .

The display unit 130 is disposed outside the housing 110 , and an image captured by the camera module may be displayed. In addition, the display unit 130 may input a signal by a user's touch.

Through the display unit 130, the patient can see the treatment process, and can move the treatment site for accurate treatment. According to an embodiment, an image photographed through a camera module installed inside the housing 110 may be displayed on the display unit 130 . To this end, a camera module for photographing the treatment space inside the housing 110 may be provided.

The cover 140 is mounted on the inlet 110A, and may be opened when the fungal infection treatment apparatus 100 is used and closed when not in use. 3 shows a state in which the cover 140 is closed, and FIG. 4 shows a state in which the cover 140 is opened.

5 is a diagram illustrating a treatment module mounted in the interior of FIG. 2 , and FIGS. 6 and 7 are diagrams illustrating a use state of the treatment module of FIG. 5 .

5 to 7 , the treatment module 200 is mounted in the inner space of the fungal infection treatment apparatus 100 and can be irradiated with light of a set wavelength to treat fungi and athlete's foot. Hereinafter, each treatment module is defined as a component that irradiates a laser and treats a treatment site of a patient with a fungus.

In one embodiment, two treatment modules 200 may be disposed on the left and right. For example, the first treatment module 200A and the second treatment module 200B may be disposed on the left side, and the first treatment module 200A and the second treatment module 200B may be disposed on the right side. The first treatment module 200A and the second treatment module 200B may irradiate light having different wavelengths.

In another embodiment, the treatment module 200 may be arranged one on each of the left and right sides, or three or more on each.

For example, a partition 116 may be installed between the treatment module on the left side and the treatment module on the right side.

The light irradiated from the first treatment module 200A and the second treatment module 200B has a cross-section of a line shape. The light irradiated from the first treatment module 200A forms a first line L1 , and the light irradiated from the second treatment module 200B forms a second line L2 . The treatment site of the patient is aligned at the point A.P where the first line L1 and the second line L2 intersect, and the treatment of the fungus is performed at the treatment site. That is, the part for treating athlete's foot in the patient is the point A.P where the first line (L1) and the second line (L2) intersect.

The patient can position the treatment site at the intersection point (A.P) while moving the nail or toenail. According to an embodiment, a camera for photographing the treatment space may be installed inside the fungal infection treatment apparatus 100 . Since the image acquired through the camera is displayed on the display unit 130, the patient can move the hand or foot to align the treatment site to the intersection point A.P.

As the treatment progresses, the patient can change the treatment site by moving his or her hand or foot. In order to treat at least one treatment site, the patient moves a hand or foot while looking at the display unit 130 , whereby the treatment site may be changed.

The first treatment module 200A and the second treatment module 200B have a fixed position. The first treatment module 200A and the second treatment module 200B may be mounted on the first frame 115 to have their positions fixed. Since the first frame 115 has an inclination, the first treatment module 200A and the second treatment module 200B may be fixed to be inclined along the inclined surface. Accordingly, the first line L1 formed by the light irradiated from the first treatment module 200A and the second line L2 formed by the light irradiated from the second treatment module 200B may cross each other.

In one embodiment, the first treatment module 200A and the second treatment module 200B may irradiate a laser. The first treatment module 200A may be a 635 nm laser light module, and the second treatment module 200B may be a 405 nm laser light module.

The first treatment module 200A and the second treatment module 200B may emit light having different wavelengths. The light from the first treatment module 200A may increase immune cells, increase blood flow, increase cell regeneration, and destroy fungal cell walls, and the light from the second treatment module 200B may generate active oxygen to kill fungi.

Light with a wavelength of 405 nm (violet) activates NADPH oxidase, a photoreceptor, to help generate reactive oxygen species (ROS). goes on

Meanwhile, light with a wavelength of 635 nm (red) activates cytochrome c oxidase (CCO), a photoreceptor, to increase adenosine triphosphate (ATP) and reactive oxygen species (ROS). The increase in ATP activates the nitric oxide synthase (eNOS) pathway and produces nitric oxide (NO), which destroys the cell wall of the fungus and improves blood circulation in the area.

In addition, ROS is rapidly converted into H2O2, and two types of immune cells use H2O2 to destroy the fungal cell wall.

The wavelength of the first treatment module 200A may be set longer than the wavelength of the second treatment module 200B. For example, the first treatment module 200A may radiate light having a wavelength between 550 and 700 nm, and the second treatment module 200B may radiate light having a wavelength between 350 and 450 nm. Preferably, the first treatment module 200A may radiate light of 635 nm, and the second treatment module 200B may radiate a wavelength of 405 nm.

The first line L1 and the second line L2 have different wavelengths, and the point A.P where the first line L1 and the second line L2 intersect has different wavelengths overlapping each other and strong energy can be formed. Therefore, at the intersection (A.P), the fungus is killed and the regenerative power is increased at the same time, thereby increasing the treatment efficiency.

In one embodiment, the fungal infection treatment apparatus 100 may further include a sensor unit 145 . The sensor unit 145 may check the opening and closing of the cover 140 . When the cover 140 is opened, the controller may prepare an operation for driving the first treatment module 200A and the second treatment module 200B.

FIG. 8 is a perspective view illustrating the treatment module 200 of FIG. 5 , and FIG. 9 is a diagram illustrating a cross-section of the treatment module 200 of FIG. 8 .

8 and 9 , the treatment module 200 includes a laser unit 210 , a bearing 220 , a first driving end 230 , a lens frame 240 , a lens 250 , and a connection member 260 . , a driving unit 270 and a second driving end 280 may be provided.

The laser unit 210 may include a first case 211 , a second case 212 , a control module 213 , and a light source 214 . The second case 212 may be disposed inside the first case 211 , and the control module 213 and the light source 214 may be disposed inside the second case 212 . The light source 214 may be set in various ways according to the wavelength oscillated by the laser unit 210 . The light source 214 may include an LED module. However, the present invention is not limited thereto, and the light source 214 may be a laser.

In order to increase the cooling effect of the treatment module 200, the first case 211 disposed outside may be formed of a metal material. For example, the first case 211 mounted on the outside of the treatment module 200 may be formed of aluminum in order to perform the role of air-cooling cooling.

The control module 213 may be a PCB. The control module 213 may receive power and may be electrically connected to the light source 214 .

The bearing 220 is disposed between the laser unit 210 and the first driving end 230 . The inner surface of the bearing 220 may be disposed to surround the lower portion of the laser unit 210 , and the outer surface of the bearing 220 may be disposed to contact the inner surface of the first driving end 230 .

The bearing 220 rotatably couples the first driving end 230 to the laser unit 210 . Therefore, when the first driving stage 230 rotates, the laser unit 210 does not rotate, but is fixed. Therefore, the control module 213 and the light source 214 included in the laser unit 210 do not rotate, and may be stably fixed even when the treatment module 200 is driven.

Since the first driving end 230 is attached to or fixedly coupled to the lens frame 240 , the lens frame 240 may rotate when the first driving end 230 rotates. For example, the lower surface of the first driving end 230 may be fixedly attached to at least a portion of the upper surface of the lens frame 240 .

The lens 250 may be mounted in the center of the lens frame 240 . The lens 250 is fixedly coupled to the lens frame 240 . Accordingly, when the lens frame 240 rotates, the lens 250 also rotates. The lens 250 transforms the cross section of the light emitted from the light source 214 into a line shape. Accordingly, as the lens 250 rotates, the line drawn by the cross-section of the light rotates.

Due to the bearing 220 , the laser unit 210 including the control module 213 and the light source 214 maintains a stable fixed state, and only the lens 250 disposed below the discharge end of the light source 214 . You can rotate the line of light while rotating.

The first driving end 230 is connected to the second driving end 280 by a connecting member 260 . When the driving unit 270 is driven, the second driving end 280 may rotate, and the first driving stage 230 may also rotate through the connecting member 260 . Since the first driving end 230 is coupled to the lens frame 240 , the lens frame 240 may also be rotated by the rotation of the first driving end 230 .

The lens frame 240 is connected to the first driving end 230 and may rotate together with the rotation of the first driving end 230 . A lens 250 is disposed inside the lens frame 240 , and the laser oscillated from the laser unit 210 may pass through the lens 250 to form a line.

The lens 250 is made of a glass-based material, and may be disposed to face the discharge end of the light source 214 . The discharge end of the light source 214 and the lens 250 may face each other with a small distance (eg, several to several tens of mm) therebetween only enough to not rub. Light emitted from the light source 214 may be directly incident on the lens 250 . Since the lens 250 and the light source 214 are disposed adjacent to each other, the laser light may be incident on the lens 250 without loss of energy of the laser light.

In order to inject the laser light into the lens 250 without loss of energy, the light source 214 may be disposed under the laser unit 210 . For example, the discharge end of the light source 214 may be located near the lower end of the first case 211 or the second case 212 . In addition, the control module 213 may be positioned above the light source 214 in the first and second cases.

The treatment module 200 is fixed to the first frame 115 . Accordingly, the positions of the laser unit 210 and the driving unit 270 are fixed. For example, the laser unit 210 may be fixed to the first frame 115 . However, the first driving stage 230 , the lens frame 240 , and the lens 250 may be rotatably connected to the laser unit 210 . When the driving unit 270 is driven, the first driving stage 230 rotates, and the lens frame 240 and the lens 250 also rotate, thereby rotating the emitted laser line. Because the laser line is rotated, it can treat a wide range of treatments.

The first treatment module 200A and the second treatment module 200B may be disposed and driven so that the crossing point A.P is fixed even when the first line L1 and the second line L2 rotate. Therefore, the patient can maximize the effect by fixing the area to be treated at the intersection point (A.P). In addition, the first line L1 and the second line L2 rotate around the intersection point A.P, so that the treatment effect may be transmitted to the periphery of the treatment unit.

10 is a block diagram illustrating a partial configuration of an apparatus for treating a fungal infection according to an embodiment of the present invention.

Referring to FIG. 10 , the fungal infection treatment apparatus 100 has a light amount compensation function, so that the light irradiated from the treatment module 200 can maintain the light amount in an appropriate range for treating the fungus.

The fungal infection treatment apparatus 100 may include a power supply unit 310 , a treatment module driver 320 , a light quantity measurement unit 330 , and a compensation unit 340 .

The power supply unit 310 may apply at least one of current and power to the treatment module 200 by driving the treatment module driver 320 . The power supply unit 310 may include an AC/DC converter that converts AC power into DC power.

The power supply unit 310 initially applies a current or voltage at a level lower than the maximum allowable current or maximum allowable voltage, but when it is determined that the amount of light irradiated from the treatment module 200 is not at an appropriate level for treatment, increase the current or voltage to increase the output of the treatment module 200 .

The treatment module driver 320 may control the current or voltage applied to the treatment module 200 . According to the signal of the treatment module driver 320 , the light source 214 of the treatment module 200 may have current or voltage adjusted, so that the light measured in the treatment space may maintain an appropriate range for treating the fungus.

The treatment module driving unit 320 applies a current or voltage less than the maximum allowable current or the maximum allowable voltage of the treatment module 200 to the treatment module 200 in the first mode of the fungal infection treatment apparatus 100, and a light quantity measurement unit The second mode is activated when the amount of light measured at 330 is less than or equal to the reference light amount, and a current or voltage greater than the voltage or current of the first mode may be applied to the treatment module 200 .

The treatment module driving unit 320 is for current control of the light source 214 of the treatment module 200 in a PWM (Pulse Width Modulation) method, for example, may be a device including a DC/DC converter.

The light amount measurement unit 330 may measure the amount of light irradiated to the treatment space. The light amount measurement unit 330 may measure the amount of light irradiated from the treatment module 200 and transmit the measured data to the compensation unit 340 .

11 and 12 are views showing the arrangement of the light quantity measuring unit of FIG. 10 .

Referring to FIG. 11 , the light quantity measuring unit 330 is a point at which the first line L1 irradiated from the first treatment module 200A and the second line L2 irradiated from the second treatment module 200B intersect. (A.P) may be located.

In one embodiment, the first treatment module 200A and the second treatment module 200B irradiate light of different wavelength bands from each light source. Even if the light amount measurement unit 330 is disposed at the intersection point A.P, the light amount measurement unit 330 measures the amount of light in a plurality of wavelength bands, and the amount of light irradiated from the first treatment module 200A and the second treatment module ( 200B) can measure the amount of light irradiated from each other.

In another embodiment, the fungal infection treatment apparatus 100 measures the light amount by first driving one of the first treatment module 200A and the second treatment module 200B when measuring the light amount. Thereafter, the light amount may be measured by driving the other one of the first treatment module 200A and the second treatment module 200B.

Referring to FIG. 12 , a plurality of light quantity measuring units may be provided. The first light amount measurement unit 330A and the second light amount measurement unit 330B may be disposed to be spaced apart from each other.

The patient places his/her foot at the intersection point (AP) to treat the fungus. The first light quantity measuring unit 330A and the second light quantity measuring unit 330B are spaced apart from each other and spaced apart from the intersection point AP, while treating the patient's feet with the fungal infection treatment apparatus 100 at the same time The amount of light can be measured.

The compensation unit 340 may transmit a compensation signal to the treatment module driver 320 so that the amount of light measured by the light amount measurement unit 330 is greater than a preset light amount. The compensation unit 340 may transmit a compensation signal to the treatment module driver 320 to increase at least one of a current and a voltage applied to the treatment module 200 . The compensation unit 340 is activated when the amount of light measured by the light amount measurement unit 330 is equal to or less than a preset reference light amount.

In one embodiment, the compensation unit 340 may control the current or voltage applied to the first treatment module and the second treatment module by pulse width modulation (PWM).

The compensation signal is generated when the light amount measured by the light amount measurement unit 330 is detected to be less than the reference light amount. The compensation signal is transmitted to the treatment module driver 320 to increase the power or current applied to the light source 214 of the treatment module 200 in order to increase the output of the amount of light in the treatment space.

The compensation unit 340 may include a compensation signal generation unit 350 and a reference light amount comparison unit 360 . The reference light amount comparison unit 360 compares the light amount measured by the light amount measurement unit 330 with the reference light amount. If the measured light amount is greater than the reference light amount, no compensation signal is generated.

When it is determined that the light amount measured by the reference light amount comparator 360 is less than or equal to the reference light amount, the data is transmitted to the compensation signal generator 350 . The compensation signal generator 350 generates a compensation signal and transmits the compensation signal to the treatment module driver 320 .

The treatment module driver 320 receiving the compensation signal applies a higher current to the light source 214 than before, or applies a higher voltage to the light source 214 than before. Accordingly, the amount of light oscillated from the light source 214 and output to the treatment space may exceed the reference light amount.

In one embodiment, the fungal infection treatment apparatus 100 measures the light amount of the first treatment module 200A and the second treatment module 200B, respectively, in the light amount measurement unit 330 . Based on the respective data measured by the light quantity measurement unit 330 , the treatment module driver 320 applies compensation signals to the first treatment module 200A and the second treatment module 200B, respectively, so that the first treatment module Both 200A and the second treatment module 200B may maintain an appropriate level of light for treatment.

13 is a graph showing the control of the amount of light and current or voltage according to the driving of the apparatus for treating a fungal infection according to an embodiment of the present invention, and FIG. 14 is the amount of light of the apparatus for treating a fungal infection according to another embodiment of the present invention. It is a flowchart showing the control method.

Referring to FIGS. 13 and 14 , the fungal infection treatment apparatus 100 is initially driven in the first mode to output a light quantity above a certain level, and is driven in the second mode, which is a compensation mode, when the light quantity output is lowered.

Hereinafter, the reference light amount LE0 is defined as the light amount of the lowest level irradiated to the treatment space in the treatment module 200 for fungal treatment. The plurality of treatment modules may each have a reference light quantity.

In the first mode, the fungal infection treatment apparatus 100 outputs a light amount higher than the reference light amount LE0 by the treatment module 200 .

When initially driven, the treatment module driver 320 controls the treatment module 200 to irradiate the first voltage V1 and/or the second light having the first light amount LE1 higher than the reference light amount LE0 to the treatment space. 1 A current C1 is applied to the treatment module 200 .

In this case, the first voltage V1 is set to be less than the maximum allowable voltage of the power supply unit 310 , and the first current C1 is set to be less than the maximum allowable current of the power supply unit 310 . That is, a current or voltage lower than the maximum current or maximum voltage that the power supply unit 310 can generate is applied to the treatment module 200 .

The light quantity measurement unit 330 measures the quantity of light emitted from the treatment module 200 to the treatment space ( S10 ).

The reference light amount comparison unit 360 compares the light amount measured by the light amount measurement unit 330 with the reference light amount LE0.

When the measured light amount is greater than the reference light amount LE0 , the treatment module driver 320 applies the same current or voltage to the treatment module 200 as before.

When the measured light amount is less than or equal to the reference light amount LE0, the compensation signal generator 350 generates a compensation signal, and the treatment module driver compensates the current or voltage (S30).

When the second mode (compensation mode) is activated, the compensation unit 340 generates a compensation signal by pulse width modulation (PWM). When the compensation signal is transmitted to the treatment module driver 320 , the treatment module driver 320 applies a second voltage V2 greater than the first voltage V1 to the treatment module 200 , or a first current C1 . A larger second current C2 is applied to the treatment module 200 .

At this time, the second voltage V2 is set to the maximum allowable voltage level of the power supply unit 310 . For example, the second voltage V2 may be equal to the maximum allowable voltage of the power supply unit 310 . The second current C2 is set to the maximum allowable current level of the power supply unit 310 . For example, the second current C2 may be equal to the maximum allowable current of the power supply unit 310 .

That is, in the compensation mode, since the maximum current level or maximum voltage level that the power supply unit 310 can generate is applied to the treatment module 200 , the amount of light irradiated from the treatment module 200 increases. 13 , when the compensation mode is started, the amount of light measured by the light amount measuring unit 330 is rapidly increased.

The conventional device for treating athlete's foot reduces the amount of light irradiated for fungal treatment. If the number of times and time of use of the device increases, the set wavelength or the set amount of light may not be satisfied. For example, when a treatment module is manufactured with an LED module, it meets the wavelength and/or light quantity set for treatment for approximately 7000 hours, but if the use time increases, the input power becomes unstable, deteriorates, foreign substances are generated in the lens, or the lens becomes cloudy. , the wavelength and/or light quantity of the irradiated light changes.

In the fungal infection treatment apparatus, light having a set amount of light in a range of wavelengths set in each treatment module should be irradiated to the fungus. However, if the usage time of the fungal infection treatment device increases, light of a wavelength different from the set wavelength is irradiated or the amount of light is insufficient, so that the efficiency of fungal treatment may be reduced.

In the fungal infection treatment apparatus 100 according to the present invention, the first treatment module 200A and the second treatment module 200B are configured by the treatment module driving unit 320 , the light quantity measurement unit 330 , and the compensation unit 340 . Light having a set light amount range in each set wavelength range may be irradiated to the treatment space.

In one embodiment, the compensation unit 340 generates a compensation signal for controlling the current or voltage transmitted to the first treatment module 200A and the second treatment module 200B, and generates the first treatment module 200A and the second treatment module 200B. 2 Each light (or laser) irradiated from the treatment module 200B may maintain a constant amount of light.

In detail, the first treatment module 200A and the second treatment module 200B operate at a level of 70 to 80% of the maximum allowable current or voltage of the power supply unit 310 in the first mode. Since the treatment module driver 320 applies a current or voltage of 70 to 80% of the maximum allowable current or voltage to the first treatment module 200A and the second treatment module 200B, the first treatment module 200A and The first light amount LE1 less than the maximum light amount of the second treatment module 200B is irradiated. At this time, since the irradiated first light quantity LE1 is greater than the reference light quantity LE0, the light irradiated from the treatment module 200 can effectively treat the fungus.

In the second mode, the compensation unit 340 generates a compensation signal for controlling current or voltage and transmits the compensation signal to the treatment module driver 320 , so that the first treatment module 200A and the second treatment module 200B) increases the amount of irradiated light. Although the amount of light irradiated from the first treatment module 200A and the second treatment module 200B is reduced due to repeated use of the fungal infection treatment apparatus 100 , the compensation unit 340 compensates for the reduced light amount. Since the compensation signal for increasing the current or voltage is generated, the first treatment module 200A and the second treatment module 200B may continuously irradiate light having a light amount greater than the reference light amount LE0.

The first treatment module 200A and the second treatment module 200B are initially set to irradiate an amount of light LE1 smaller than the maximum amount of light LE2, and then when it is sensed that the amount of irradiated light decreases, the current value is adjusted The light irradiated from the first treatment module 200A and the second treatment module 200B by generating a compensation signal may maintain a preset amount of light.

A method of adjusting the amount of light irradiated from the fungal infection treatment apparatus 100 may be set manually or automatically. In the automatic mode, when the light quantity measurement unit 330 senses the light quantity irradiated from the treatment module 200 , the compensation unit 340 may automatically generate a compensation signal to compensate for this. In the manual mode, when the light quantity measurement unit 330 senses the light quantity irradiated from the treatment module 200, the user may adjust the light quantity by adjusting the input current value.

In another embodiment, the compensation unit 340 generates a compensation signal for controlling the current delivered to the first treatment module 200A and the second treatment module 200B, and the first treatment module 200A and the second treatment module 200B. Each light (or laser) irradiated from the module 200B may maintain a wavelength in a preset range.

In detail, the first treatment module 200A and the second treatment module 200B operate at a level of 70 to 80% of the maximum allowable current or voltage of the power supply unit 310 in the first mode. The treatment module driver 320 applies a current or voltage at a level of 70 to 80% of the maximum allowable current or voltage to the first treatment module 200A and the second treatment module 200B, the first treatment module 200A and In the second treatment module 200B, light of a target wavelength is irradiated for treatment.

Thereafter, the wavelength may be changed by continuous use of the fungal infection treatment apparatus 100 . A wavelength measuring unit (not shown) may measure wavelengths of light irradiated from the first treatment module 200A and the second treatment module 200B. The compensation unit may adjust the current or voltage so that the first treatment module 200A and the second treatment module 200B respectively irradiate light having a set wavelength range, based on the wavelength measured by the wavelength measuring unit.

For example, the compensation unit transmits a compensation signal to the treatment module driver. The compensation signal is a signal for maintaining the light irradiated from the treatment module in a preset wavelength band. When the treatment module driver receives the compensation signal, the first treatment module 200A and the second treatment module 200B may each irradiate light of a set band by adjusting the voltage or current.

A method of adjusting the wavelength irradiated from the fungal infection treatment apparatus 100 may be set manually or automatically. In the automatic mode, when the wavelength measuring unit measures the wavelength irradiated from the treatment module, the compensation unit may automatically generate a compensation signal to correct it. In the manual mode, when the wavelength measuring unit senses the wavelength irradiated from the treatment module, the user may adjust the wavelength by adjusting the input current value.

In another embodiment, the compensation unit 340 generates a compensation signal for controlling the current transmitted to the first treatment module 200A and the second treatment module 200B, and the first treatment module 200A and the second treatment module 200B. Each light (or laser) irradiated from the treatment module 200B may maintain a light quantity and wavelength within a preset range.

The first treatment module 200A and the second treatment module 200B operate at a level of 70 to 80% of the maximum allowable current or voltage of the power supply unit 310 in the first mode. The treatment module driver 320 applies a current or voltage at a level of 70 to 80% of the maximum allowable current or voltage to the first treatment module 200A and the second treatment module 200B, the first treatment module 200A and The second treatment module 200B is irradiated with light having a target wavelength and light quantity for treatment.

Thereafter, the wavelength and the amount of light may be changed by continuous use of the fungal infection treatment apparatus 100 . The light quantity measuring unit 330 and the wavelength measuring unit (not shown) may measure the light quantity and the wavelength of the light irradiated from the first treatment module 200A and the second treatment module 200B, respectively. The compensation unit may adjust the current or voltage so that the first treatment module 200A and the second treatment module 200B respectively irradiate light within a set light amount range, based on the light amount measured by the light amount measurement unit. In addition, the compensation unit may adjust the current or voltage so that the first treatment module 200A and the second treatment module 200B respectively irradiate light having a set wavelength range, based on the wavelength measured by the wavelength measuring unit.

For example, the compensation unit transmits a compensation signal to the treatment module driver. The compensation signal is a signal for maintaining a preset amount of light and a wavelength band for the light irradiated from the treatment module. When the treatment module driver receives the compensation signal, the first treatment module 200A and the second treatment module 200B may emit light having a set amount and wavelength, respectively, by adjusting voltage or current.

The compensation unit is a device for regulating current or voltage, and may be implemented as, for example, an electric circuit. The compensation unit may control currents applied to the first treatment module and the second treatment module by pulse width modulation (PWM).

In another embodiment, the fungal treatment apparatus may be controlled as follows.

In an embodiment, the operator may measure the wavelength and/or the amount of light of the treatment module with a measuring device (not shown), and may directly adjust the wavelength and/or the amount of light of the treatment module. In this case, the operator may control the current or voltage through the treatment module driver to adjust the wavelength and/or the amount of light of the treatment module.

In another embodiment, when the light quantity measuring unit senses the light quantity or the wavelength measuring sensor measures the wavelength, data about the light quantity or wavelength is transmitted to the remote device. The operator may control the remote device to adjust the wavelength and/or light quantity of the treatment module.

In another embodiment, when the light quantity measurement unit senses the light quantity or the wavelength measurement sensor measures the wavelength, the compensation unit generates a compensation signal in real time, and the treatment module driver receiving the compensation signal controls the current or voltage The wavelength and/or light quantity of the treatment module may be adjusted.

Since the fungal infection treatment apparatus 100 according to the present invention has a set amount or wavelength of light irradiated from the treatment module, high treatment efficiency can be maintained even when used for a long time. When the amount of light irradiated from the treatment module changes or the wavelength changes, the compensation unit generates a compensation signal, and the treatment module driver receives the compensation signal and adjusts the power or current applied to the treatment module, suitable for fungal treatment. The amount of light and wavelength can be maintained continuously, and the use time can be extended.

The spirit of the present invention should not be limited to the above-described embodiments, and not only the claims described below, but also all ranges equivalent to or changed from these claims are within the scope of the spirit of the present invention. will be said to belong

100: fungal infection treatment device
110: housing
200: treatment module
210: laser unit
220: bearing
310: power unit
320: treatment module driving unit
330: light quantity measurement unit
340: reward unit

Claims (1)

housing;
a treatment space formed inside the housing and capable of accommodating a treatment site;
a treatment module irradiating light to the treatment space;
a light amount measuring unit for measuring the amount of light irradiated to the treatment space; and
A treatment module driver configured to drive the treatment module so that the amount of light measured by the light amount measurement unit maintains a preset range;
Fungal infection treatment device.

Images